Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

11.41

+0.93 (8.87%)

At close: Feb 6, 2026, 4:00 PM EST

11.62

+0.21 (1.84%)

After-hours: Feb 6, 2026, 7:49 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Medicines for Childhood and Adult Diseases with Equal Intensity	131.16M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
United States	131.16M